Mirxes successfully held a hearing at the Hong Kong Stock Exchange for listing.

According to the Hong Kong Stock Exchange file, on May 12, Mirxes Holding Company Limited went through a listing hearing on the Hong Kong Stock Exchange, with China International Capital Corporation and China Merchants Securities (International) Co., Ltd. as its joint sponsors. Mirxes was founded in 2014 and is a Singapore-based company specializing in microRNA technology. Its core product, GASTROClearTM, is a blood-based miRNA detection kit consisting of 12 miRNA biomarkers for gastric cancer screening.